Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03460873

Enrollment

432

Registered

2018-03-09

Start date

2015-09-30

Completion date

2019-11-28

Last updated

2019-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia (BPH)

Brief summary

Prognostic factor in the patients with benign prostatic hyperplasia (BPH) who undergo holmium laser enucleation of the prostate

Interventions

PROCEDUREholmium laser enucleation of the prostate

undergo holmium laser enucleation of the prostate

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Healthy volunteers

Inclusion criteria

* Male patient scheduled to undergo prostatectomy using holmium laser

Exclusion criteria

* Urethral stricture, large bladder diverticulum, bladder neck contracture

Design outcomes

Primary

Measure	Time frame	Description
Comparison of IPSS(International Prostate Symptom Score) changes	pre-operation and post-operation (3month, 6month)	Complete the questionnaire(IPSS) before and after the treatment

Secondary

Measure	Time frame	Description
changes of voided urine volume	pre-operation and post-operation (3month, 6month)	Comparison of voided urine volume
changes of residual urine volume	pre-operation and post-operation (3month, 6month)	Comparison of residual urine volume
Occurrence of adverse event	post-operation (3month, 6month)	collection of adverse event

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026